Literature DB >> 30036414

Nasal airway obstruction: Prevalence and anatomic contributors.

David W Clark1, Anthony G Del Signore, Roheen Raithatha, Brent A Senior.   

Abstract

Surgical treatments for nasal airway obstruction (NAO) are commonly offered as part of otolaryngology practice. Anatomic causes include septal deviation, inferior turbinate hypertrophy, and nasal valve collapse (NVC). This study was performed to determine the prevalence of anatomic contributors to NAO. A total of 1,906 patients with sinonasal complaints were surveyed by 50 otolaryngologists in varying U.S. geographic regions. Patients were first evaluated using the Nasal Obstruction Symptom Evaluation (NOSE) instrument to assess the NAO symptoms and their severity. Physicians then examined patients for the presence of the three anatomic contributors. Presence of septal deviation and turbinate hypertrophy was assessed through an internal nasal exam with direct or endoscopic visualization based on the physician's standard methodology for diagnosis. Presence of NVC was determined by the modified Cottle maneuver. Among all patients surveyed, prevalence was 67% for NVC, 76% for septal deviation, and 72% for inferior turbinate hypertrophy. We found that 64% of the patients (n = 1,211) had severe/extreme NOSE scores (≥55), representing the most likely nasal obstruction candidates for intervention. In these patients, the prevalence of NVC, septal deviation, and inferior turbinate hypertrophy was 73, 80, and 77%, respectively. Eighty-two percent of the 236 patients with severe/extreme NOSE scores who reported prior septoplasty and/or inferior turbinate reduction had NVC. Our study revealed a comparable prevalence of all three anatomic contributors across all patients and the subset with severe/extreme NOSE scores, highlighting the importance of evaluating the lateral nasal wall as a component of NAO treatment strategy.

Entities:  

Mesh:

Year:  2018        PMID: 30036414     DOI: 10.1177/014556131809700615

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  6 in total

1.  Assessment of bioabsorbable implant treatment for nasal valve collapse compared to a sham group: a randomized control trial.

Authors:  Pablo Stolovitzky; Brent Senior; Randall A Ow; Neelesh Mehendale; Nadim Bikhazi; Douglas M Sidle
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-21       Impact factor: 3.858

2.  A clinical and histopathological comparison of saline, adrenaline and 2-mercaptoethanesulfonate (MESNA) in mucoperichondrial elevation: which is superior?

Authors:  Zehra Çınar; Özgür Yiğit; Fulya Savran Turanoğlu; Sevim Baykal Koca
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

3.  Association of nasal septal deviation with the incidence of anxiety, depression, and migraine: A national population-based study.

Authors:  Ki-Il Lee; Seung Min In; Jong-Yeup Kim; Jee-Young Hong; Kyung-Do Han; Jung-Soo Kim; Yong Gi Jung
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

4.  The prevalence of non-allergic rhinitis phenotypes in the general population: A cross-sectional study.

Authors:  Klementina S Avdeeva; Wytske J Fokkens; Christine L Segboer; Sietze Reitsma
Journal:  Allergy       Date:  2022-01-25       Impact factor: 14.710

5.  Internal Nasal Valve Modification via Correction of High Dorsal Deviation Using a Modified Mattress Suture Technique.

Authors:  Joongbo Shin; Jungkyu Cho; Sang Duk Hong; Yong Gi Jung; Gwanghui Ryu; Hyo Yeol Kim
Journal:  J Clin Med       Date:  2022-10-05       Impact factor: 4.964

6.  Temperature-controlled radiofrequency device treatment of the nasal valve for nasal airway obstruction: A randomized controlled trial.

Authors:  Stacey L Silvers; Jon N Rosenthal; Chad M McDuffie; David M Yen; Joseph K Han
Journal:  Int Forum Allergy Rhinol       Date:  2021-07-09       Impact factor: 5.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.